Javascript must be enabled to continue!
Endothelin-Induced Contraction of the Portal Vein in Cirrhosis
View through CrossRef
Endothelin (ET) is one of the most potent vasoconstrictors known so far. It has been proposed that the ET-induced contraction of hepatic stellate cells (Ito, endothelial cells) is an important mechanism for the development of portal hypertension. The purpose of this study was to investigate in an in vitro model whether ET causes a contraction of the portal vein which can contribute to portal hypertension in cirrhosis. Portal veins from normal and cirrhotic rats were used for experiments. Measurements were performed in vitro for cumulative concentrations of ET-1 and ET-3 (1, 5, 10, 50 and 100 n<i>M</i>). Both ETs caused a dose-dependent increase in portal venous tension; the maximal tension (T<sub>max</sub>) was measured at 50 n<i>M</i>. The measured T<sub>max</sub> was higher for cirrhotic (ET-1: T<sub>max</sub> = 189%; ET-3: T<sub>max</sub> = 175%) than for normal rats (ET-1: T<sub>max</sub> = 130%; ET-3: T<sub>max</sub> = 151%). ET-3 produced a higher tension of portal veins in normal rats than ET-1. In conclusion, this study shows that portal veins from cirrhotic rats react more sensitively to ET than those from normal rats. Besides the ET-induced contraction of hepatic stellate cells, contraction of the portal vein and its intrahepatic branches, especially in cirrhotic individuals, has to be considered as a further mechanism of ET contributing to portal hypertension.
Title: Endothelin-Induced Contraction of the Portal Vein in Cirrhosis
Description:
Endothelin (ET) is one of the most potent vasoconstrictors known so far.
It has been proposed that the ET-induced contraction of hepatic stellate cells (Ito, endothelial cells) is an important mechanism for the development of portal hypertension.
The purpose of this study was to investigate in an in vitro model whether ET causes a contraction of the portal vein which can contribute to portal hypertension in cirrhosis.
Portal veins from normal and cirrhotic rats were used for experiments.
Measurements were performed in vitro for cumulative concentrations of ET-1 and ET-3 (1, 5, 10, 50 and 100 n<i>M</i>).
Both ETs caused a dose-dependent increase in portal venous tension; the maximal tension (T<sub>max</sub>) was measured at 50 n<i>M</i>.
The measured T<sub>max</sub> was higher for cirrhotic (ET-1: T<sub>max</sub> = 189%; ET-3: T<sub>max</sub> = 175%) than for normal rats (ET-1: T<sub>max</sub> = 130%; ET-3: T<sub>max</sub> = 151%).
ET-3 produced a higher tension of portal veins in normal rats than ET-1.
In conclusion, this study shows that portal veins from cirrhotic rats react more sensitively to ET than those from normal rats.
Besides the ET-induced contraction of hepatic stellate cells, contraction of the portal vein and its intrahepatic branches, especially in cirrhotic individuals, has to be considered as a further mechanism of ET contributing to portal hypertension.
Related Results
Portal Vein Invasion Secondary to Hepatic Hydatid Disease: A Rare Case Report
Portal Vein Invasion Secondary to Hepatic Hydatid Disease: A Rare Case Report
Background
Hydatid cyst disease is a zoonotic parasitic infection caused by
Echinococcus
spec...
Effectiveness of Enalapril Versus Nifedipine to Antagonize Blood Pressure and the Renal Response to Endothelin in Humans
Effectiveness of Enalapril Versus Nifedipine to Antagonize Blood Pressure and the Renal Response to Endothelin in Humans
Abstract
Endothelin-1 infusion into humans to obtain pathophysiological plasma levels causes mild hypertension, strong renal vasoconstriction, and sodium retention. We ...
Response to Endothelin-1 in Arteries from Human Colorectal Tumours: Role of Endothelin Receptors
Response to Endothelin-1 in Arteries from Human Colorectal Tumours: Role of Endothelin Receptors
To examine the reaction of tumour arteries to endothelin-1, we obtained arteries supplying blood flow to colorectal tumours from patients, as well as mesenteric arteries supplying ...
PORTAL VEIN THROMBOSIS – A STUDY OF RISK FACTORS, CLINICAL PROFILE, COMPLICATIONS AND MANAGEMENT
PORTAL VEIN THROMBOSIS – A STUDY OF RISK FACTORS, CLINICAL PROFILE, COMPLICATIONS AND MANAGEMENT
Background: The portal vein is formed by the conuence of the splenic and superior mesenteric veins. Occlusion of the portal vein by thrombus
(portal vein thrombosis [PVT]) typical...
Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart.
Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart.
BACKGROUND
Based on recent evidence showing that endothelin-1 stimulates several activation mechanisms on neutrophils, the aim of the present study was to analyze the e...
Proton pump inhibitor treatment aggravates bacterial translocation in patients with advanced cirrhosis and portal hypertension
Proton pump inhibitor treatment aggravates bacterial translocation in patients with advanced cirrhosis and portal hypertension
ABSTRACT
Recent studies have linked proton pump inhibitor (PPI) treatment to increased complications of cirrhosis, such as bacterial infections and hepatic e...
Endothelin stimulates platelet-activating factor synthesis by cultured rat Kupffer cells
Endothelin stimulates platelet-activating factor synthesis by cultured rat Kupffer cells
Endothelins are potent peptide mediators that elicit glycogenolytic and vasoconstrictor actions in the liver. Endothelins were found to stimulate the synthesis and release of the l...
Paraumbilical vein patency in cirrhosis: Effects on hepatic hemodynamics evaluated by doppler sonography
Paraumbilical vein patency in cirrhosis: Effects on hepatic hemodynamics evaluated by doppler sonography
Doppler sonographic portal vein parameters are used for the noninvasive evaluation of portal hypertension in cirrhosis. The patency of a paraumbilical vein is a rather frequent fin...

